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Background: Occlusion of blood vessels using high-intensity focused ultrasound (HIFU) is a potential treatment for
arteriovenous malformations and other neurovascular disorders. However, attempting HIFU-induced vessel occlusion
can also cause vessel rupture, resulting in hemorrhage. Possible rupture mechanisms include mechanical effects of
acoustic cavitation and heating of the vessel wall.
Methods: HIFU exposures were performed on 18 ex vivo porcine femoral arteries with simultaneous passive
cavitation detection. Vessels were insonified by a 3.3-MHz focused source with spatial-peak, temporal-peak focal
intensity of 15,690–24,430 W/cm2 (peak negative-pressure range 10.92–12.52 MPa) and a 50% duty cycle for
durations up to 5 min. Time-dependent acoustic emissions were recorded by an unfocused passive cavitation
detector and quantified within low-frequency (10–30 kHz), broadband (0.3–1.1 MHz), and subharmonic (1.65 MHz)
bands. Vessel rupture was detected by inline metering of saline flow, recorded throughout each treatment.
Recorded emissions were grouped into ‘pre-rupture’ (0–10 s prior to measured point of vessel rupture) and
‘intact-vessel’ (>10 s prior to measured point of vessel rupture) emissions. Receiver operating characteristic curve
analysis was used to assess the ability of emissions within each frequency band to predict vessel rupture.
Based on these measurements associating acoustic emissions with vessel rupture, a real-time feedback control
module was implemented to monitor acoustic emissions during HIFU treatment and adjust the ultrasound intensity,
with the goal of maximizing acoustic power delivered to the vessel while avoiding rupture. This feedback control
approach was tested on 10 paired HIFU exposures of porcine femoral and subclavian arteries, in which the focal
intensity was stepwise increased from 9,117 W/cm2 spatial-peak temporal-peak (SPTP) to a maximum of 21,980 W/cm2,
with power modulated based on the measured subharmonic emission amplitude. Time to rupture was compared
between these feedback-controlled trials and paired controller-inactive trials using a paired Wilcoxon signed-rank test.
Results: Subharmonic emissions were found to be the most predictive of vessel rupture (areas under the receiver
operating characteristic curve (AUROC) = 0.757, p < 10−16) compared to low-frequency (AUROC = 0.657, p < 10−11) and
broadband (AUROC = 0.729, p < 10−16) emissions. An independent-sample t test comparing pre-rupture to intact-vessel
emissions revealed a statistically significant difference between the two groups for broadband and subharmonic
emissions (p < 10−3), but not for low-frequency emissions (p = 0.058).
In a one-sided paired Wilcoxon signed-rank test, activation of the control module was shown to increase the time to
vessel rupture (T− = 8, p = 0.0244, N = 10). In one-sided paired t tests, activation of the control module was shown to
cause no significant difference in time-averaged focal intensity (t = 0.362, p = 0.363, N = 10), but was shown to cause
delivery of significantly greater total acoustic energy (t = 2.037, p = 0.0361, N = 10).
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Conclusions: These results suggest that acoustic cavitation plays an important role in HIFU-induced vessel rupture. In
HIFU treatments for vessel occlusion, passive monitoring of acoustic emissions may be useful in avoiding hemorrhage
due to vessel rupture, as shown in the rupture suppression experiments.
Keywords: High-intensity focused ultrasound, Vessel occlusion, Passive cavitation detection, Rupture suppressionIntroduction
High-intensity focused ultrasound (HIFU) is a thera-
peutic modality with multiple clinical applications [1],
many of which involve tissue ablation for treating of
neoplastic pathology [2]. Neurosurgical applications of
HIFU have been investigated since the early work of the
Fry brothers [3,4]. HIFU has also been shown to occlude
in vivo blood vessels in animal models [5-16]. This could
have neurosurgical applications in pre-operative occlu-
sion of feeding arteries to arteriovenous malformations
(AVM) or large tumors, as is already performed with
endovascular therapy.
While previous in vivo experiments have shown that
HIFU-induced vessel occlusion is feasible, they have also
demonstrated a risk of hemorrhage. In a recent paper
[16] summarizing results from multiple studies of HIFU-
induced vessel occlusion [5-14,17-20], vessel rupture was
found to occur in some studies for 13% to 80% of the ves-
sels targeted for occlusion [6-9,14]. Using a 1.49-MHz
transducer with focal intensities 4,400–8,800 W/cm2,
Hynynen et al. [6] occluded 19/27 sonicated rabbit
femoral arteries and veins (diameter 1–1.3 mm), but
found increased hemorrhage rates at higher intensities
(hemorrhage in 0/3 vessels treated at 4,400–5,300 W/cm2,
4/19 vessels treated at 5,800–6,300 W/cm2, and 1/4 ves-
sels treated at 7,300–8,800 W/cm2). In another study
using a 1.5-MHz transducer with focal intensities of
2,800–6,500 W/cm2 to noninvasively occlude segmental
rabbit renal arteries (0.6-mm diameter), the same group
identified contrast extravasation on X-ray angiography in
2/9 vessels [7]. Rivens et al., using a 1.7-MHz transducer
at a focal intensity of 4,660 W/cm2, occluded 4/10 rat
femoral arteries and veins (0.5–1.5 mm), but detected
hemorrhage by magnetic resonance angiography in 8/10
cases [8]. The same group, using a 1.7-MHz transducer to
occlude rat femoral arteries and veins at intensities of
1,000–4,660 W/cm2, occluded 100% of vessels at spatial
peak intensities of 1,690 W/cm2 without hemorrhage, but
again demonstrated hemorrhage in both vessels treated at
4,660 W/cm2 [9]. More recently, Ichihara, using a higher
frequency transducer (2.2 MHz) with focal intensity of
4,000 W/cm2 for occlusion of segmental renal arteries
in rabbits, found hemorrhage by contrast ultrasound on
3/8 cases [14].
Thus, although vessel occlusion has been demonstrated
with HIFU for in vivo animal models, hemorrhage canoccur under many exposure conditions within the range
of interest investigated for occlusion. In a clinical setting,
hemorrhage within the central nervous system, also a
concern for ultrasound-enhanced thrombolysis [21] and
therapeutic opening of the blood–brain barrier [22], can
lead to catastrophic neurologic damage. Therefore, causes
and possible mitigation for hemorrhage risks must be
addressed prior to clinical application of HIFU for blood
vessel occlusion in the central nervous system.
The mechanisms of vessel rupture after application of
HIFU are presently unclear. One possible mechanism is
supratherapeutic heating of the vessel wall. Hynynen et al.
[7] reported that hemorrhage occurred after retreatment
of previously treated constricted vessels, leading them to
conclude that HIFU-generated heat was not dissipated
due to reduced convection, causing supratherapeutic heat-
ing and vessel rupture. In a study evaluating the effects of
argon lasers on rat carotid arteries, Martinot et al. [23]
noticed severe tissue disorganization and perforation at
temperatures greater than 100°C. Mechanical damage can
also be caused by local tissue boiling, even at short
duration, with radiation force playing a concomitant role
[24]. Heating to 100°C, which causes tissue vaporization
(boiling), has also been shown to cause mechanical
damage such as cracking in thermally ablated tissue
[25]. Tissue vaporization can be detected by low-frequency
emissions [25-27].
Another possible mechanism of HIFU-induced vessel
hemorrhage is the mechanical effects of cavitation. Iner-
tial cavitation, or the violent collapse of microbubbles in
an ultrasound field, is known to cause high-velocity
microjets as well as concentrated high pressure and tem-
perature, resulting in substantial mechanical damage to
tissue under some conditions [28-31]. Tissue homoge-
nization by the mechanical effects of inertial cavitation, a
process known as histotripsy, has been applied to thromb-
olysis [32] and perforation of the atrial septum [33]. In
addition, stable cavitation, or the sustained large-ampli-
tude oscillation of microbubbles in an ultrasound field, is
believed to cause mechanical effects due to microstream-
ing [34]. Bioeffects associated with stable cavitation are
believed to include ultrasound-enhanced thrombolysis
[35,36] as well as enhanced permeability of blood vessels
[37], opening of the blood–brain barrier [38], and in-
creased transdermal drug delivery with sonophoresis
[39]. Mechanical effects of cavitation may also combine
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force. Acoustic cavitation activity can be detected from
passively recorded acoustic emissions, with stable cavita-
tion signified by subharmonic and ultraharmonic (i.e.,
integer multiples of subharmonic frequencies) emissions
and inertial cavitation signified by broadband acoustic
emissions associated with bubble collapse [40,41]. Passive
cavitation detection has been previously employed in
multiple studies of ultrasound ablation [25,42-45].
The first part of the study reported here, testing pre-
diction of vessel rupture, employed application of HIFU
(3.3 MHz) to ex vivo porcine superficial femoral arteries
with passive cavitation detection while monitoring for
rupture. This portion of the study tested the hypothesis
that passively detected emissions during HIFU application
to ex vivo vessels can predict impending vessel rupture,
with the goal of providing insight into mechanisms of
HIFU-induced vessel rupture.
If vessel rupture could be predicted with sufficient
accuracy from measured emissions, passive cavitation
detection could be used during vessel occlusion with
HIFU in a clinical setting. Feedback based on measured
acoustic emissions could vary sonication amplitudes, po-
tentially allowing greater HIFU energy delivery while
avoiding activity predictive of vessel rupture. A similar
approach was recently employed for the application of
blood–brain barrier disruption, using feedback control
to modulate the amplitude of focused ultrasound to
achieve stable cavitation while avoiding inertial cavitation
[46]. For the application of vessel occlusion, analysis of
previous in vivo experiments [16,47] has suggested that
occlusion may be achieved by a complex cascade of events,
possibly involving narrowing of the lumen by vascular
spasm and radiation force, heating of the vessel wall to
temperatures causing coagulation of collagen, edema of
surrounding tissue, thermal and mechanical damage to the
endothelium, activation and aggregation of platelets, and
intraluminal thrombus formation. Feedback control could
potentially allow occlusion to be achieved by allowing
greater delivery of acoustic energy and thus increased heat-
ing of the vessel wall, while avoiding acoustic emissions
predictive of vessel rupture.
Based on the results of the rupture prediction experi-
ments performed here, which show the successful pre-
diction of vessel rupture from measured subharmonic
acoustic emissions, a real-time feedback control module
was implemented and tested using a setup adapted from
the prediction experiments. Ex vivo porcine superficial
femoral arteries and subclavian arteries were subjected
to 3.3-MHz HIFU controlled by this feedback module.
HIFU intensity was modulated by the feedback control
unit based on measured subharmonic emissions, using
a threshold determined empirically from results of the
rupture prediction experiments. This rupture suppressionstudy had the major goal to determine whether passive
detection of acoustic emissions, coupled with real-time
feedback for HIFU intensity modulation, could delay
vessel rupture, thus potentially improving the safety and
efficacy of HIFU vessel occlusion.
Materials and methods
Rupture prediction experiments: experimental methods
The experiments reported here employed sonication of
ex vivo porcine arteries by a 3.3-MHz HIFU transducer,
with inline measurements of flow rate to detect rupture
and a passive cavitation detector (PCD) to monitor bubble
activity. An overview of the experimental setup is shown
in Figure 1A. An open-loop fluid circuit was created with
plastic tubing and a peristaltic pump. A 3-cm segment of
porcine superficial femoral artery was interposed in the
flow circuit by cannulation of 19-gauge needles into both
ends. A peristaltic pump buffered by a closed air chamber
created continuous flow of degassed saline through the
circuit. The HIFU transducer was fixed over the vessel
and the PCD was fixed at the level of the vessel, both
perpendicular to the flow of saline.
Due to their ease of harvest and comparable size to po-
tential targets of vessel occlusion (2–3 mm), the bilateral
superficial femoral arteries of swine were harvested for
this study. Necropsy was performed on two swine within
1 h postmortem. These animals were supplied and sacri-
ficed by a different investigator under a protocol approved
by the Institutional Animal Care and Use Committee
(IACUC) of the University of Cincinnati. Branching ves-
sels of the superficial femoral arteries were ligated with
silk suture. The vessels were stored at 4°C in 0.9% saline
solution with 2 g dextrose per liter. The sonications were
performed within 48 h postmortem. The vessels were
suspended in degassed 0.9% phosphate-buffered saline so-
lution in an acrylic cuvet with degassed saline circulated
by a peristaltic pump (Harvard Apparatus, Holliston, MA,
USA) through the vessel at 63 mL/min during insonation.
The peristaltic flow was buffered by allowing air com-
pression via a T-connector to a closed syringe to smooth
transient fluctuations in the flow velocity. The container
with the treated vessel was placed into deionized water in
a 10-gallon tank where an unfocused PCD (Panametrics
NDT V302, 1 MHz, Billerica, MD, USA) was submerged
(Figure 1C). The PCD was fixed in the same position rela-
tive to the vessel and HIFU transducer for all trials, ensur-
ing that its sensitivity to HIFU-induced acoustic emissions
was equivalent throughout all experiments.
Flow through the vessel was monitored with a flow meter
(KOBOLD DPM Pelton wheel flow sensor, Pittsburgh, PA,
USA) interfaced with a low-level direct current (DC) data
logger (Madgetech Process101A, Warner, NH, USA),
which sampled the flow-meter output current at 1 Hz. For
an unruptured vessel, the flow-meter output current was
Figure 1 Schematic showing experiment layout, experimental setup for rupture suppression, and Intra-procedural photograph showing
positions of HIFU transducer. (A) Schematic showing the experiment layout for rupture prediction trials. (B) Experimental setup for rupture
suppression trials utilizing active feedback using a custom control module. (C) Intra-procedural photograph showing positions of the HIFU transducer,
PCD, and ex vivo vessel.
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rupture was thus defined as a 3% decrease in the flow-
meter output current. In order to synchronize flow mea-
surements with PCD-measured acoustic emissions, the
timing of rupture detection was determined by meas-
uring the delay between manual vessel puncture with
a 23-gauge needle and 3% decrease in the flow-meter
output. This delay was found to be 8 s within measure-
ment precision, and thus, the instant of vessel rupture was
defined as 8 s prior to detection of a 3% decrease in the
flow-meter output.The 3.3-MHz spherically focused transducer (Sonic
Concepts, Bothell, WA, USA) used for insonation of the
vessels (Figure 1) had a surface area of 34.6 cm2 and
focal length of 62.6 mm, resulting in a focal width of
0.42 mm and a focal depth of 3.3 mm. A plastic cone
attached to the transducer face enclosed the prefocal
acoustic propagation path. The transducer and cone
were suspended in deionized, degassed water within a
latex sheath (Sheathing Technologies Inc., Morgan Hill,
CA, USA), which was then placed within the cuvet con-
taining the vessel in saline. The saturation of dissolved
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of insonations (range 13.5–19.5%). Vessel targeting was
done by manual placement of the cone tip above the
vessel. An ultrasonic pulser-receiver (Panametrics Model
5052UAX50, Billerica, MD, USA) was then used for pulse-
echo ranging of the vessel relative to the HIFU transducer,
with echo amplitude observed on a digital oscilloscope
(LeCroy WaveRunner 6050A, Chestnut Ridge, NY, USA).
The HIFU transducer was scanned using a two-axis step-
ping motor system (Velmex VXM 2, Bloomfield, NY,
USA) to maximize echo amplitude, with the goal of pre-
cisely focusing the HIFU field on the proximal vessel wall,
within the main sensitivity pattern of the unfocused PCD.
For each ruptured vessel, a small puncture was observed
at this focal location on the proximal vessel wall.
Insonations were performed at 3.3 MHz in 0.5-s inter-
vals with 0.5-s pauses (1 Hz, 50% duty cycle) for up to
300 cycles (5 min) or until vessel rupture was detected.
This pulsing scheme allowed the PCD signal from the
entire 0.5-s duration of a HIFU pulse to be recorded be-
fore commencement of the next pulse, so that acoustic
emission data was recorded whenever the vessel was
subjected to HIFU. The time limit of 300 s was chosen
to exceed durations of all previously published trials
demonstrating successful vessel occlusion by HIFU, for
which the maximum stated treatment duration was 180 s
[16]. Waveforms were synthesized by a signal generator
(Agilent 33220A, Santa Clara, CA, USA), triggered by a
second function generator (Philips PH 5193, Seattle, WA,
USA), amplified by a 50-dB radiofrequency power
amplifier (ENI 3100 L, Kent, WA, USA), and transmit-
ted to the HIFU transducer through an impedance match-
ing network (Sonic Concepts, Bothell, WA, USA).
Rupture prediction experiments: data processing
Acoustic emissions detected by the PCD were amplified
by a low-noise preamplifier with amplitude gain 100
(Stanford Research Systems SR560, Sunnyvale, CA, USA).
This preamplifier also performed high-pass filtering with a
cutoff frequency of 10 kHz and slope of 12 dB/octave. The
amplified and filtered PCD signals were then recorded by
a digital oscilloscope (LeCroy WaveRunner 6050A, Chest-
nut Ridge, NY, USA) at a sampling rate of 10 MHz. PCD
signals of length 5,000,000 samples were recorded for each
0.5-s sonication cycle throughout each sonication trial.
PCD emissions were manually synchronized with the
recorded flow data with 1-s precision.
To estimate the focal intensity incurred by the vessel,
acoustic power measurements were taken using a radiation
force balance with a cone reflector (Ohmic Instruments
UPM-DT-10, Easton, MD, USA). Acoustic power was
measured for the input range 50–350 mVpp at 50-mVpp
intervals, amplified by the same radiofrequency amplifier
used in the sonication trials. Acoustic power for intermediateinput voltages was estimated by linear interpolation. For
the range of sonication amplitudes employed in the trials
described below, measured acoustic power ranged from
20.28–32.75 W. These measured acoustic power read-
ings were used as inputs to a simulation employing
the KZK equation [48], along with the appropriate trans-
ducer dimensions and assuming water as the propagation
medium, to estimate the corresponding spatial-peak, tem-
poral-peak (SPTP) focal intensities as 15,690–24,430
W/cm2, corresponding to peak negative pressures of
10.92–12.09 MPa (HIFU Simulator v1.2 by Joshua Soneson,
US Food and Drug Administration; MATLAB R2011a, The
MathWorks, Natick, MA, USA).
HIFU exposure conditions for the 18 trials reported
here are shown in Table 1. Trial sonications at lower
intensities (three trials with estimated SPTP focal intensity
12,429 W/cm2) resulted in no vessel ruptures and were
thus excluded from analysis.
Acoustic emissions were quantified by spectral analysis
of the PCD signals using custom software written in
MATLAB. Each 5,000,000-point, 0.5-s PCD signal was
split into 1,000 segments of length 5,000 samples with
no overlap. To estimate power spectra for each 0.5-s
PCD signal, the discrete Fourier transform of each seg-
ment was computed and the squared magnitudes of the
1,000 individual segments were averaged. The resulting
frequency resolution was 10 kHz. To quantify the elec-
tronic noise background, reference PCD signals for each
trial were obtained prior to insonation, with all equipment
powered on but the function generator, and these refer-
ence noise signals were processed in the same manner.
In order to differentiate between the various types of
bubble activity, measured power spectra were integrated
over specific frequency bands, similar to a previous study
[25]. The integrated signal power was then divided by the
integrated power of the reference noise signal for the same
band, resulting in a computed time-dependent signal-to-
noise ratio (SNR) for each emission type. Emission energy
within a low-frequency (10–30 kHz) band was associated
with tissue or fluid vaporization and boiling [26,27]. To
characterize broadband emissions associated with inertial
cavitation, measured power spectra were integrated from
0.3–1.1 MHz [25]. Subharmonic emission energy from the
single bin at 1.65 MHz was also quantified as an indicator
of stable cavitation [40,41]. Due to the nonuniform
frequency response of the PCD, comparisons between
low-frequency, broadband, and subharmonic emissions
could not be performed.
PCD signal energy within each of these bands was
computed for each 0.5-s sonication interval, yielding
time-dependent low-frequency, broadband, and subhar-
monic signal levels with 1-s temporal resolution. In
order to test the potential of passive cavitation detection
to predict vessel rupture, individual PCD signal spectra












1 250 20.28 15,690 10.92 29
2 250 20.28 15,690 10.92 133
3 275 26.45 20,570 11.83 27
4 275 26.45 20,570 11.83 25
5 275 26.45 20,570 11.83 NR
6 275 26.45 20,570 11.83 NR
7 280 26.96 20,940 11.90 NR
8 285 27.53 21,350 11.97 14
9 285 27.53 21,350 11.97 32
10 300 28.42 21,980 12.09 55
11 300 28.42 21,980 12.09 41
12 300 28.42 21,980 12.09 60
13 300 28.42 21,980 12.09 19
14 300 28.42 21,980 12.09 133
15 300 28.42 21,980 12.09 35
16 325 32.06 24,430 12.52 55
17 325 32.06 24,430 12.52 67
18 325 32.06 24,430 12.52 42
In trials 5–7, NR indicates that no rupture occurred. AWG arbitrary waveform generator.
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prior to the estimated instant of rupture) or ‘intact-vessel’
emissions (more than 10 s prior to the instant of rupture).
The duration of 10 s for the pre-rupture period was
chosen, based on observation of measured acoustic emis-
sions, to capture the main temporal variations in emission
levels, while smoothing out short-lived statistical fluctua-
tions. The effect of window length was assessed in a
post hoc study, in which receiver operating characteristic
curves were computed for window lengths of 1–20 s.
Statistical analysis included comparison of low-frequency,
broadband, and subharmonic emission levels between
pre-rupture and intact-vessel emissions as well as receiver
operating characteristic (ROC) curve analysis to test pre-
diction of vessel rupture based on each emission level.
These analyses were performed using custom software
written in MATLAB. Primary analysis included all mea-
sured acoustic emissions, up to the time of vessel rupture
or the 5-min time limit, from all 18 trials.
Two-tailed, independent-sample t tests were performed
comparing intact-vessel emissions to pre-rupture emis-
sions, with assumption of equal but unknown variance. In
addition, means and standard errors of the mean (SEM)
were computed for the measured energy of pre-rupture
and nonrupture low-frequency, broadband, and subhar-
monic emissions. These analyses were performed for all
18 trials, with the significance criterion p < 0.05.Receiver operating characteristic (ROC) curves, which
plot sensitivity and specificity of a binary classifier as a
function of a predictive parameter (test variable) threshold,
were computed to assess the utility of passive cavitation
detection for predicting vessel rupture. In this analysis,
carried out separately for measured low-frequency, broad-
band, and subharmonic emissions, test variables were the
measured emission levels for each 0.5-s PCD signal, while
state variables were the classification of each PCD signal
as a nonrupture or pre-rupture emission. Plotting the
true-positive rate (sensitivity) vs. the false-positive rate
(1−specificity) results in an ROC curve. Area under
the ROC curve is an indicator of prediction success,
with area 1 indicating a perfect predictor and area 0.5
indicating performance no better than chance. Statistical
significance of each predictor was assessed vs. the null
hypothesis of area 0.5, with the significance criterion
p < 0.05.
Rupture suppression experiments
Using the data obtained from the vessel rupture predic-
tion study, a control module was designed to actively
monitor the HIFU treatment and adjust ultrasound in-
tensity in an attempt to maximize acoustic power sup-
plied to the treated vessels while avoiding rupture. Since
subharmonic emissions were found most predictive of
vessel rupture, measured subharmonic emissions were
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the sonication amplitude to avoid acoustic cavitation.
The setup for these experiments, similar to the rupture
prediction experiments except for the adjustments in
HIFU exposure levels, is shown in Figure 1B.
In rupture suppression trials, porcine subclavian and
bilateral superficial femoral arteries were exposed to
focused ultrasound as in the above rupture prediction
experiments, starting with a 9,117 W/cm2 SPTP focal
intensity and increased stepwise by the controller to a
maximum of 21,980 W/cm2 SPTP. Trials were deemed
either ‘controller-active’ or ‘controller-inactive.’ In con-
troller-active trials, a monitoring module decreased the
sonication amplitude whenever measured subharmonic
emissions exceeded a pre-defined threshold, defined below.
A flow diagram for the controller actions is detailed in
Figure 2. For comparison, paired controller-inactive trials,
with the feedback controller disabled, were performed on
vessel segments from the same length of artery on the
same day. As for the rupture prediction experiments,
sonications were limited to 300 s, a time exceeding that
required for HIFU vessel occlusion in previously published
studies [16].
Emissions recorded by the PCD were filtered by a
1.65-MHz bandpass filter before amplification by the
same pre-amplifier employed in the rupture prediction
experiments (gain 20,000) and sent to the monitoring
module, in which the signal was half-wave rectified,Figure 2 Flow chart detailing the vessel rupture suppression protoco
the time the transducer is off, the emissions are processed and a calculated
threshold, the ultrasound intensity is decreased. If the threshold is not reac
(up to a maximum of 24,430 W/cm2). This process is repeated for a total ofpassed through a 1,063-Hz AM demodulator, and con-
verted to a digital signal by the onboard microcontroller at
a sampling rate of 68.6 kHz. RMS subharmonic emission
values were computed from these signal-envelope samples
for each 0.5-s insonation, resulting in time-dependent sub-
harmonic emission recordings with a temporal resolution
of 1 s. Emissions were recorded by the oscilloscope for veri-
fication, but were not used in postprocessing.
The subharmonic threshold value used by the controller
module was determined by simulating the effects of
the feedback-controller signal chain on PCD signals previ-
ously measured in the rupture prediction experiments.
Transfer functions of the preamplifier, 1.65-MHz band-
pass filter, and half-wave rectifier/AM demodulator
combination were modeled in MATLAB, and previously
measured PCD signals were subjected to these transfer
functions in the given order. Receiver operating charac-
teristic curves were then generated in the same manner as
for the rupture prediction experiments, and the point on
the ROC curve simultaneously maximizing sensitivity and
specificity (i.e., the point closest to the corner [0,1]) was
determined. To obtain a more conservative threshold ap-
propriate for avoidance of vessel rupture, the measured
RMS noise level was then subtracted 1.5 times from the
threshold simultaneously maximizing sensitivity and spe-
cificity. For this adjusted threshold, found to be 0.06 VRMS,
the simulated sensitivity based on data from the rupture
prediction study was 0.606; specificity was 0.702; positivel. Subharmonic emissions are acquired while the HIFU is active. During
value compared to a given threshold. If this value surpasses the
hed for ten consecutive counts (10 s), the intensity is increased
300 cycles.
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value (NPV) was 0.939.
Statistical analysis was performed to compare time to
rupture for the controller-active and controller-inactive
groups, the trial-average ultrasound intensity, and the
total acoustic energy delivered. Analysis included all
measured subharmonic emissions and intensities, up to
the point of rupture, for all experiment pairs. If a treated
vessel did not rupture after the 300-s exposure, the rup-
ture time was conservatively defined as 300 s for these
analyses. A one-sided paired Wilcoxon signed-rank test,
which compares the population mean ranks of two
samples, was utilized to determine if the controller-
active trials had a longer time to vessel rupture than the
controller-inactive cases. Single-sided, paired t tests were
performed to compare the time-averaged, spatial-peak-
temporal peak focal intensity and the total acoustic energy
delivered during the controller-active and controller-in-
active trials, testing the hypotheses that the controller
allowed delivery of greater time-averaged focal intensity
and greater total acoustic energy. The criterion for statis-
tical significance in all statistical tests was p < 0.05.
Results
Rupture prediction experiments
Of the 18 vessels sonicated in the rupture prediction
experiments, 15 vessels ruptured prior to 300 s of sonic-
ation, while 3 vessels were sonicated for 300 s without
rupture. Times to rupture, together with HIFU exposure
conditions for each trial, are shown in Table 1. SPTP
focal intensities varied from 15,690–24,430 W/cm2. No
rupture occurred for two trials at SPTP 20,570 W/cm2
and one trial at 20,940 W/cm2. For the 15 vessels that
ruptured, the mean sonication time to rupture was 51 s
(range = 14–133 s, standard deviation = 37 s). For the 15
ruptured vessels, time to rupture was not significantly
correlated with focal intensity (r = −0.1814, p = 0.5177).
Representative plots of measured low-frequency, broad-
band, and subharmonic acoustic emissions during inso-
nation are displayed as decibel-scaled SNR levels in
Figures 3, 4, and 5. Figures 3A, 4A, and 5A show mea-
sured PCD power spectra as a function of time and
frequency for trials 5 (20,570 W/cm2, no rupture), 8
(21,350 W/cm2, rupture at 14 s), and 15 (21,980 W/cm2,
rupture at 35 s). Spectrograms are shown for two fre-
quency ranges, 0–1.5 MHz (including low-frequency and
broadband emissions) and 1.5–1.8 MHz (including subhar-
monic emissions), with different dynamic ranges chosen to
distinctly display emissions within both bands. Figures 3B,
4B, and 5B show the corresponding measured time-
dependent low-frequency, broadband, and subharmonic
emission levels for the same trials, together with the syn-
chronously measured flow-meter output current. Broad-
band emissions in all three of these cases are measured atmean levels >5 dB SNR and are slightly higher in the trials
resulting in vessel rupture. Low-frequency and subhar-
monic emissions are substantially larger in trials 8 and 15,
with vessel rupture (Figures 4 and 5), compared to trial 5,
without vessel rupture (Figure 3).
Qualitative assessment of time-dependent emissions
levels from all trials showed several common trends. In
many cases, low-frequency, broadband, or subharmonic
levels were elevated immediately after initiation of sonic-
ation, then markedly declined within 10–20 s. These
higher initial levels were likely caused by residual gas
bubbles, which were then eliminated by the high-intensity
sonication. Relative initial levels for the three emission
types varied between trials, but were generally highest
for low-frequency emissions and smallest for broadband
emissions. For example, in Figure 3B, the subharmonic
emission level is elevated immediately after sonication
begins, then declines to near baseline levels within about
10 s. Similarly, in Figure 5B, low-frequency emission levels
at the start of sonication are elevated to near the max-
imum level achieved later in the exposure.
Subharmonic emissions were generally lower for non-
rupture trials. The highest subharmonic emission for any
nonrupture trial occurred immediately after commence-
ment of sonication in trial 5 (Figure 3). Figure 4B shows
typical trends for the trials resulting in vessel rupture. After
the initial burst, emission levels in each frequency band
steadily increase over time until the vessel ruptures. How-
ever, in some cases, including that shown in Figure 5B,
low-frequency and broadband emissions did not increase
steadily, and no clear relation between vessel rupture and
the time-dependent emission levels was evident.
Statistical comparison of pre-rupture emissions (all
emissions within 10 s prior to rupture) to intact-vessel
emissions (all emissions greater than 10 s before rupture
and all emissions from the nonruptured trials) were per-
formed based on the measured signal energy of each
emission type from each 0.5-s PCD signal. Averaged
pre-rupture emission level energies, quantified as decibel-
scaled SNR, were 17.71, 15.49, and 1.18 dB for the low-
frequency, broadband and subharmonic frequency bands,
respectively. Corresponding levels were 16.03, 12.67, and
0.58 dB for intact-vessel emissions. The mean and stand-
ard error of each emission level for pre-rupture and
intact-vessel emissions, as SNR without logarithmic scal-
ing, are shown in Figure 6. An independent-sample t test,
comparing intact-vessel emissions to pre-rupture emis-
sions with assumption of equal variance, indicates sig-
nificantly higher broadband (p < 10−19, t = 9.38, N = 18)
and subharmonic (p < 10−29, t = 11.64, N = 18) levels for
pre-rupture emissions. Low-frequency levels for pre-
rupture emissions were also higher than for intact-vessel
emissions, but this difference was not statistically signifi-
cant (p = 0.0582, t = 0.896, N = 18).
Figure 3 Spectrogram of time-dependent passive cavitation detector signals and plots of time-dependent acoustic emissions for trial
5. (A) Spectrogram of time-dependent passive cavitation detector signals (in dB-scaled SNR) for trial 5 with 20,570 W/cm2 SPTP focal intensity.
(B) Plots of time-dependent acoustic emissions (dB-scaled SNR) and flow-meter output current for trial 5. No vessel rupture occurred in this trial.
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Figure 7, indicated that passive cavitation detection of
low-frequency, broadband, and subharmonic emissions
was predictive of vessel rupture for all three emission
types. Areas under the ROC curve (AUROC) values were
0.657 (p < 10−11), 0.729 (p < 10−16), and 0.757 (p < 10−16)
for low-frequency, broadband, and subharmonic emis-
sions, respectively. These AUROC values are shown with
corresponding standard errors and confidence intervals in
Table 2.
Threshold values for each emission type to maximize
true-positive rate (sensitivity) and true-negative rate(specificity) were determined using data from all 18 trials.
These thresholds are given as decibel-scaled SNR values,
together with the resulting measured sensitivities, specific-
ities, positive predictive values, and negative predictive
values, in Table 3. Subharmonic emissions were most pre-
dictive of vessel rupture. For the subharmonic threshold,
the sensitivity was 74.5%; the specificity was 64.4%; the
positive predictive value was 19.0%; and the negative
predictive value was 95.7%.
In a post hoc study to determine the effect of the pre-
rupture period length, ROC curves were computed for
subharmonic emissions using pre-rupture periods of
Figure 4 Spectrogram of time-dependent passive cavitation detector signals and time-dependent acoustic emissions for trial 8.
(A) Spectrogram of time-dependent passive cavitation detector signals (dB-scaled SNR) for trial 8 with 21,350 W/cm2 SPTP focal intensity.
(B) Time-dependent acoustic emissions (dB-scaled SNR) and flow-meter output current for trial 8. The estimated time of vessel rupture is shown
by the dashed vertical line.
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http://www.jtultrasound.com/content/2/1/14duration 1–20 s. With this range of window lengths,
areas under the ROC curve (AUROC) were found to
range from a minimum of 0.746 to a maximum of 0.781,
varying by no more than 3.1% from the AUROC for the
chosen window length of 10 s. Thus, prediction efficacy
was determined not to depend strongly on the choice of
duration for the pre-rupture emission period.
Rupture suppression experiments
Representative plots of subharmonic emissions and flow-
meter output during the rupture suppression experiments,as recorded by the control module, are shown in Figure 8.
Figure 8A,B (vessel pair 4) shows typical trends observed
for the seven subclavian arteries employed pairs in these
experiments. In the controller-inactive trials, subharmonic
emissions typically increased greatly later in the exposures
(after about 150 s of sonication) and then remained at an
elevated level, followed by a vessel rupture shortly there-
after. In the controller-active trials, increased subharmonic
emissions typically appeared as brief spikes that were not
sustained after the HIFU sonication level was reduced by
the controller. Figure 8C,D (vessel pair 5) shows typical
Figure 5 Spectrogram of time-dependent passive cavitation detector signals and time-dependent acoustic emissions for trial 15.
(A) Spectrogram of time-dependent passive cavitation detector signals (in dB SNR) for trial 15 with 21,980 W/cm2 SPTP focal intensity.
(B) Time-dependent acoustic emissions (in dB-scaled SNR) flow-meter output current for trial 15. The estimated time of vessel rupture is shown
by the dashed vertical line.
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http://www.jtultrasound.com/content/2/1/14trends for the three femoral arteries in these experiments.
For femoral arteries in both the controller-active and
controller-inactive groups, subharmonic emissions showed
smaller amplitude spikes and did not show sustained eleva-
tions in the emission levels.
Figure 9 shows plots of the HIFU time-dependent SPTP
focal intensity for the same trials depicted in Figure 8.
Figure 9A,C shows a monotonic increase in intensity, as
specified for all controller-inactive trials. For the control-
ler-active trials illustrated in Figure 9B,D, decreases in
focal intensity occurred after the 0.06-VRMS subharmonicemission threshold was reached, triggering a 10-mVpp
decrease in the output of the function generator. In two
cases (vessel pairs 8 and 10), the subharmonic emission
threshold was never reached during the controller-active
trials.
Rupture occurrence and timing in the rupture suppres-
sion experiments is summarized in Table 4. Statistical
comparison using a one-sided, paired Wilcoxon signed-
rank test indicated that controller activation caused a
significant delay in vessel rupture (T− = 8, p = 0.0244,
N = 10). Times to rupture (mean ± standard deviation)
BA
C
Figure 6 Means and standard errors of intact-vessel and pre-rupture emission levels for all trials (N = 18). (A) Low-frequency levels.
(B) Broadband levels. (C) Subharmonic levels.
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http://www.jtultrasound.com/content/2/1/14were 242.8 ± 74.7 s for the controller-active group and
179.1 ± 76.1 s for the controller-inactive group, as illus-
trated in Figure 10A. For the ten pairs of vessels tested,
the controller-active vessel had a longer time to rupture in
seven cases; the controller-inactive vessel had a longer
time to rupture in two cases; and neither vessel rup-
tured in one case. Nine of ten vessels within the con-
troller-inactive group ruptured within the 300-s time
limit (minimum time to rupture 22 s), including three
of three femoral arteries and six of seven subclavian
arteries. Within the controller-active group, four vessels
ruptured within the 300-s time limit (minimum time to
rupture 131 s), including all three femoral arteries and one
subclavian artery.Qualitatively, femoral arteries were found to rupture
sooner than subclavian arteries in these experiments,
possibly due to their smaller wall thickness. However, in
the absence of feedback control, the fraction of vessels
rupturing was not significantly different for the two ves-
sel types (Fisher’s exact test, p = 1.0). In the presence of
feedback control, the fraction of femoral vessels ruptur-
ing within the 300-s sonication period was significantly
greater than the fraction of subclavian vessels rupturing
(Fisher’s exact test, p = 0.0333). However, the delay in
vessel rupture between controller-active and controller-
inactive states was not significantly different when com-
paring subclavian vs. femoral vessels (Student t test,
p = 0.759).
Figure 7 ROC curves for prediction of vessel rupture, based on
18 trials. Curves are shown quantifying rupture prediction
performance based on low-frequency, broadband, and subharmonic
emissions within 10 s before rupture.
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acoustic energy for the controller-active and controller-
inactive groups are illustrated in Figure 10B,C. The mean
HIFU SPTP focal intensities throughout the controller-
active and controller-inactive trials were comparable,
as shown in Figure 10B. The trial-mean focal intensity
was 19,852 ± 3,461 W/cm2 (mean ± standard deviation,
N = 10) for the controller-active trials and 19,335 ± 3,593
W/cm2 for the controller-inactive trials, a statistically
insignificant difference (one-sided, paired t test, t = 0.362,
p = 0.363, N = 10). As shown in Figure 10C, the average
acoustic energy delivered was greater for controller-active
trials (mean ± standard deviation 3,259 ± 1,323 J, N = 10)
than for controller-inactive trials (2,446 ± 1,267 J, N = 10),
a statistically significant difference (one-sided, paired t
test, t = 2.037, p = 0.0361, N = 10).
Discussion
In these trials applying HIFU to ex vivo porcine sub-
clavian and superficial femoral arteries, passive cavitation
detection results suggest that acoustic emissions can beTable 2 AUROC statistics for vessel rupture prediction by low





Areas under the ROC curves (AUROC) with corresponding standard errors (under th
hypothesis AUROC = 0.5, and 95% confidence intervals (18 trials).used to predict imminent vessel rupture and as a feedback
mechanism to suppress vessel rupture. In the rupture
prediction experiments reported here, significant increases
were observed in both subharmonic emission levels
(p < 10−29) and broadband emission levels (p < 10−19) for
pre-rupture emissions (within 10 s immediately prior to
vessel rupture) compared to intact-vessel emissions as de-
fined above. Notably, subharmonic emissions were found
to predict vessel rupture more effectively than broadband
emissions (AUROC 0.757 vs. 0.729), despite the lower
signal-to-noise ratio for subharmonic emissions in these
experiments, illustrated in Figures 3, 4, and 5. Subhar-
monic emissions predicted vessel rupture with a sensitivity
of 74.5%, specificity of 64.4%, and a negative predictive
value of 95.7%.
Results of the present rupture prediction study suggest
that sustained acoustic cavitation activity, including both
stable and inertial cavitation, is associated with vessel
rupture during HIFU application. As seen in Figures 3,
4, and 5, acoustic emission levels tended to remain rela-
tively steady or increase with time. Since acoustic cavita-
tion could only occur during the 0.5-s HIFU pulses and
not during the alternating 0.5-s rest periods, this sug-
gests that cavitation could be nucleated similarly within
each sonication pulse. Nucleation likely did not occur
within the vessel lumen, because the lumen contained
only degassed saline circulating in an open-loop flow
path. Similarly, the exterior of the vessel was surrounded
by degassed saline. Thus, bubble nucleation and acoustic
cavitation were likely isolated within the vessel wall.
HIFU-induced damage to the vessel wall, potentially
caused both by heating and by the mechanical effects of
cavitation, may have facilitated sustained bubble nucle-
ation, resulting in growing cavitation with increasing ex-
posure time. Results of both the rupture prediction and
suppression studies suggest that the likelihood of vessel
rupture increases as this cavitation activity grows.
Although the present studies show a significant link
between acoustic cavitation and vessel rupture, they do
not show that cavitation is the sole causative mechanism
for rupture. In addition to direct mechanical effects of
acoustic cavitation within the vessel wall, vessel heating
likely plays a role [16]. In the present rupture prediction
study, although low-frequency pre-rupture emissions
were not significantly greater than intact-vessel emissions,-frequency, broadband, and subharmonic emissions
p value 95% confidence interval




e nonparametric assumption), asymptotic p-values relative to the null
Table 3 Optimal emission thresholds and corresponding accuracy metrics for rupture prediction
Acoustic emission type Threshold (dB) Sensitivity Specificity PPV NPV
Low-frequency 0.863 69.6% 54.7% 14.7% 94.1%
Broadband 11.04 75.1% 62.9% 18.5% 95.7%
Subharmonic 0.499 74.5% 64.4% 19.0% 95.7%
Threshold values (in dB relative to the measured noise floor) yielding maximum sensitivity and specificity, with corresponding sensitivities, specificities, positive
predictive values (PPV), and negative predictive values (NPV), using data from 18 trials.
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boiling) were significant predictors of vessel rupture, as
shown in the ROC analysis. Low-frequency emissions
were less effective predictors than either subharmonic
or broadband emissions. These results suggest that
heating-induced tissue vaporization, associated with low-
frequency emissions, was not the primary cause of HIFU-
induced vessel rupture in these experiments. However,
tissue heating likely contributes to vessel rupture, by
mechanisms including mechanical tissue damage caused
directly by boiling [24] and indirectly by coagulative ne-
crosis, potentially weakening tissue structures and enab-
ling further mechanical damage from acoustic radiation
force, streaming, and mechanical effects of cavitation.
Therapeutic tissue heating (temperature elevations >60°C)
likely plays a greater role in coagulative occlusion of treated
blood vessels. Threshold analysis of previous experiments
on in vivo vessel coagulation [16] suggests that vessel
coagulation is more likely at higher HIFU heating rates,
consistent with the causation of occlusion by heating
rather than acoustic cavitation. Possible mechanisms for
vessel occlusion, supported by analysis of previous in vivo
occlusion studies, have suggested a complex cascade of
mechanisms for occlusion, with heating playing a majorFigure 8 Subharmonic emissions and flow rate recorded by monitorin
Subclavian artery, controller inactive, pair 4. (B) Subclavian artery, controller
(C) Femoral artery, controller inactive, pair 5. (D) Femoral artery, controllerrole through shrinkage and denaturation of collagen,
elastin fragmentation and refusion, thermal damage to
the endothelium, and tissue fusion within the vessel
wall [16,47]. The lumen is narrowed by these thermal
effects as well as smooth muscle contraction, vasospasm,
and acoustic radiation force. These combined effects re-
sult in endothelial disruption activating platelets and the
coagulation cascade and direct activation of platelets,
intraluminal thrombus formation, and potentially fibrosis
resulting in permanent occlusion [16,23,47,49].
For safe and effective application of HIFU for vascular
occlusion, further refinement in treatment methods is
needed to avoid vessel hemorrhage. The possible tech-
nique tested here was modulation of HIFU intensity
through a feedback mechanism to reduce cavitation ac-
tivity. This feedback loop triggered a reduction of the
HIFU intensity after passively detected subharmonic
emissions exceeded an empirical threshold determined
using results of the rupture prediction study. This rup-
ture suppression study showed that vessel rupture can
be significantly delayed by feedback control of HIFU
sonication amplitude based on measured subharmonic
emissions (minimum 22 s, mean 179 s, standard deviation
76 s for the controller-inactive group; minimum 131 s,g module during rupture suppression experiments. (A)
active, pair 4, subharmonic detection threshold set to 0.06.
active, pair 5, subharmonic detection threshold set to 0.06.
Figure 9 Ultrasound intensity at the focus versus time for representative trials in the vessel rupture suppression experiments.
(A) Subclavian artery, controller inactive, pair 4. (B) Subclavian artery, controller active, pair 4, subharmonic detection threshold set to 0.06.
(C) Femoral artery, controller inactive, pair 5. (D) Femoral artery, controller active, pair 5, subharmonic detection threshold set to 0.06.
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http://www.jtultrasound.com/content/2/1/14mean 243 s for the controller-active group; p < 0.03). The
feedback controller caused a statistically insignificant dif-
ference in the time-averaged focal intensity delivered to
the vessel, but allowed significantly more total acoustic
energy to be delivered (p < 0.04), indicating that rupture
suppression was associated with reducing cavitation activ-
ity rather than reducing the average HIFU exposure level.
Thus, feedback control may potentially enable greater ves-
sel heating while reducing mechanical damage associated
with cavitation.
Although the feedback controller did not cause rup-
ture to be avoided in all cases (4/10 vessels ruptured in
the controller-active group vs. 9/10 for the controller-Table 4 Time to rupture from experiment start for all vessel r











The values listed in the ‘Pair difference’ column correspond to those used in the pa
indicates that no rupture occurred during the experiment.inactive group), the significantly increased time to vessel
rupture may in practice allow vessel occlusion to be
achieved before rupture. In our ex vivo model, vessel oc-
clusion was not possible due to the lack of flowing blood
and a living vessel wall, so that the coagulation cascade
could not be initiated. For this reason, HIFU exposures
continued well beyond durations of interest for vessel
occlusion, up to a maximum of 300 s. In comparison, as
summarized in ref. [6], previous studies demonstrating
vessel occlusion by focused ultrasound have employed
treatment durations of 180 s or less, with the great ma-
jority employing exposures less than 10 s. Thus, when
used during vessel occlusion procedures, the presentupture suppression trials











ired Wilcoxon signed-rank test and the paired t test. A time to rupture of 300 s
Figure 10 Comparison of controller-inactive and controller-active trials in rupture suppression experiments. Means and standard errors
are shown for (A) time to rupture from start of sonication, (B) trial-average SPTP acoustic intensity at the focus, and (C) total acoustic energy delivered.
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ally valuable suppression of vessel rupture, substantially
reducing the likelihood of hemorrhage during HIFU vessel
occlusion, while allowing maximum delivery of HIFU en-
ergy for optimal thermal coagulation of the vessel.
Clinical application of this feedback control method to
vessel occlusion will require further refinement and val-
idation. Passive cavitation detection will need to be ef-
fectively implemented for the geometries of interest in
particular applications, including neurosurgical [16], ob-
stetric [47], and others. Optimal frequency bands for
analysis of acoustic emissions (for example, choice of
subharmonic or ultraharmonic bands to detect stable
cavitation activity) will likely depend on the HIFU fre-
quency and tissue path in the application of interest.
Spatial selectivity in cavitation detection, achievable by
passive cavitation imaging [44,50-52], may be useful,
particularly in combination with pulse-echo methods for
real-time detection of local heating, such as echo decorr-
elation imaging [53,54]. Optimal thresholds for emission
detection would need to be determined more rigorously,
with the goal of reducing hemorrhage likelihood to
clinically acceptable levels. Thresholds would need to be
determined separately based on factors including size
and type of vessel, HIFU frequency, anatomical environ-
ment, and acceptable level of risk for the clinical applica-
tion. The feedback control method will then need to be
validated in conjunction with vessel occlusion in clinically
realistic applications, testing its potential to heat of the
vessel in a safer, more controllable manner to improvetreatment efficacy while avoiding hemorrhage. Achieve-
ment of safe and consistent occlusion by this technique
would show feasibility for this technology’s future role in
neurosurgical applications [16].
Conclusion
The experiments reported here indicate the important
role of acoustic cavitation in HIFU-induced vessel rupture.
In the rupture prediction experiments, subharmonic and
broadband emissions were predictive of HIFU-induced
vessel rupture, with subharmonic emissions providing
greater predictive accuracy. This indicates that acoustic
cavitation, particularly sustained cavitation accompanied
by subharmonic emissions, may play a central role in
vessel hemorrhage during HIFU application for vessel
occlusion. Low-frequency emissions were less predict-
ive of vessel rupture, suggesting that heating-induced
tissue vaporization is not a primary mechanism of HIFU-
induced vessel rupture. Rupture suppression experiments,
implementing a real-time feedback controller to reduce
acoustic cavitation by modulating HIFU intensity, show
the potential to avoid vessel rupture during HIFU treat-
ments while still delivering significant acoustic energy.
Future investigations on vascular occlusion with HIFU may
benefit from passive monitoring and control of subhar-
monic and broadband emissions to prevent hemorrhagic
complications.
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